The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Disease relapse represents by far the most frequent cause of hematopoietic cell transplantation (HCT) failure. Patients with acute leukemia suffering relapse after HCT have limited conventional treatment options with little possibility of cure and represent, de facto, suitable candidates for the eva...

Full description

Bibliographic Details
Main Authors: Enrico Maffini, Margherita Ursi, Francesco Barbato, Michele Dicataldo, Marcello Roberto, Elena Campanini, Elisa Dan, Francesco De Felice, Serena De Matteis, Gianluca Storci, Massimiliano Bonafè, Mario Arpinati, Francesca Bonifazi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
allogeneic hematopoietic cell transplantation (HCT)
acute myeloid leukemia (AML)
disease relapse
donor lymphocyte infusion
hypomethylating agents relapse prevention in AML receiving allogeneic hematopoietic cell transplantation
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1066285/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1066285/full

Similar Items